Beam Therapeutics's top three insider shareholders as of May 30, 2026 are Llc Fmr (Other, 4.01Mn shares), Venture Partners Ix, Llc Arch (TenPercentOwner, 2.95Mn shares), John M. Evans (Ceo, 1.05Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Llc Fmr | - | 0 | 4,007,424 | 15 Feb, 2024 |
| Venture Partners Ix, Llc Arch | - | 28,111 | 2,921,519 | 02 Jul, 2021 |
| John M. Evans | Ceo | 1,047,205 | 0 | 06 Apr, 2026 |
| Giuseppe Ciaramella | President | 218,406 | 0 | 06 Apr, 2026 |
| Sravan Kumar Emany | Chief Financial Officer | 105,456 | 0 | 02 Apr, 2026 |
| Christine Bellon | Chief Legal Officer | 109,711 | 0 | 06 Apr, 2026 |
| Amy Simon | Chief Medical Officer | 102,735 | 0 | 06 Apr, 2026 |
| Bethany J Cavanagh | Svp, Finance And Treasurer | 51,171 | 0 | 06 Apr, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Christine Bellon | Common Stock | D | 5,956 | $24.58 | 109,711 | D | S |
| 01 Apr, 2026 | Amy Simon | Common Stock | D | 6,700 | $24.58 | 102,735 | D | S |
| 01 Apr, 2026 | Christine Bellon | Common Stock | D | 5,956 | $24.58 | 109,711 | D | S |
| 01 Apr, 2026 | Giuseppe Ciaramella | Common Stock | D | 11,810 | $24.58 | 218,406 | D | S |
| 01 Apr, 2026 | Giuseppe Ciaramella | Common Stock | D | 11,810 | $24.58 | 218,406 | D | S |
| 01 Apr, 2026 | Amy Simon | Common Stock | D | 6,700 | $24.58 | 102,735 | D | S |
| 01 Apr, 2026 | Bethany J Cavanagh | Common Stock | D | 3,242 | $24.58 | 51,171 | D | S |
| 01 Apr, 2026 | John M. Evans | Common Stock | D | 30,078 | $24.58 | 1,047,205 | D | S |
| 31 Mar, 2026 | Giuseppe Ciaramella | Common Stock | A | 40,000 | $0.00 | 230,216 | D | A |
| 31 Mar, 2026 | Amy Simon | Common Stock | A | 31,750 | $0.00 | 109,114 | D | A |
| 31 Mar, 2026 | Amy Simon | Common Stock | A | 31,750 | $0.00 | 109,114 | D | A |
| 31 Mar, 2026 | Amy Simon | Common Stock | A | 31,750 | $0.00 | 109,114 | D | A |
| 31 Mar, 2026 | Giuseppe Ciaramella | Common Stock | A | 40,000 | $0.00 | 230,216 | D | A |
| 31 Mar, 2026 | Christine Bellon | Common Stock | A | 20,000 | $0.00 | 115,667 | D | A |
| 31 Mar, 2026 | Christine Bellon | Common Stock | A | 20,000 | $0.00 | 115,667 | D | A |
| 31 Mar, 2026 | Christine Bellon | Common Stock | A | 20,000 | $0.00 | 115,667 | D | A |
| 31 Mar, 2026 | Sravan Kumar Emany | Common Stock | A | 31,750 | $0.00 | 105,456 | D | A |
| 31 Mar, 2026 | Giuseppe Ciaramella | Common Stock | A | 40,000 | $0.00 | 230,216 | D | A |
| 24 Feb, 2026 | Giuseppe Ciaramella | Common Stock | A | 35,000 | $17.00 | 225,216 | D | M |
| 24 Feb, 2026 | Giuseppe Ciaramella | Common Stock | A | 35,000 | $17.00 | 225,216 | D | M |